Anti-Amyloid-β Immunotherapy in Alzheimer's Disease: ACC-001 Clinical Trials Are Ongoing
Publisher:
Journal of Alzheimer's DiseaseDate published:
19 June, 2009Region:
United States of America Publication type:
researchFeatured item on home page:
no
Wyeth Pharmaceuticals, Collegeville, PA, USA
Elan Pharmaceuticals, San Francisco, CA, USA
Pay-Per-View Copyright Statement
Similar content
- Testing the amyloid hypothesis of Alzheimer's disease in vivo
- Copyright
- PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab...
- Alzheimer's Disease Neuroimaging Initiative Announces Completion Of Genome-Wide Analysis
- The annual Alzheimer Society of Ireland's Tea Day
- Amyloid-β immunisation for Alzheimer's disease
- Phil Hope to lead push to increase dementia research
- Audio slideshow: Loving and living with Alzheimer's
- Preventing injuries and fatalities among older pedestrians (Letter to the Editor)
- Immune therapy Alzheimer's hope